The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system built for the future of veterinary care. PHILADELPHIA, The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system built for the future of veterinary care. PHILADELPHIA,

Instinct Science Acquires ScribbleVet to Deliver the Next Generation of Intelligent-Native Veterinary Practice Management Software

The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system built for the future of veterinary care.

PHILADELPHIA, Jan. 16, 2026 /PRNewswire/ — Instinct Science, the company behind leading veterinary practice management system Instinct EMR as well as Standards of Care, Plumb’s, and Clinician’s Brief, today announced its acquisition of ScribbleVet, a market-leading veterinary AI scribing platform, marking a defining moment in the evolution of veterinary practice management software.

Together, Instinct and ScribbleVet are creating a new category of practice management system: the industry’s first clinical intelligence platform, designed to move beyond record-keeping and deliver intelligence-native workflows and trusted decision support in a single, intuitive system that reduces administrative burden, increases efficiency, and fundamentally changes how veterinary teams work.

For decades, practice management systems have focused on storing information. The combined Instinct platform is designed to do far more: actively support care delivery through hands-free documentation, embedded clinical intelligence, and workflows that adapt to how modern veterinary practices operate.

As part of the acquisition, ScribbleVet’s team will join Instinct Science. ScribbleVet founder and CEO Rohan Relan will assume a key leadership role at Instinct, leading product strategy for Intelligence products across the platform.

“We are entering a new and exciting era for veterinary medicine,” said Dr. Caleb Frankel, Founder and CEO of Instinct Science. “At Instinct, we believe thoughtfully designed AI and ambient medical note technology are core to this future. In bringing ScribbleVet and their incredible team into Instinct, we are doubling down on our vision of building the software system our profession deserves. By combining best-in-class AI, workflow, and clinical decision support, we are redefining what practice management software should be.”

The combined platform will enable veterinary teams to:

  • Focus entirely on patients with AI scribing embedded directly into the workflow
  • Dramatically reduce documentation burden and administrative friction
  • Access trusted clinical decision support, including Plumb’s, at the point of care
  • Use a single, intuitive system designed for doctors, technicians, and staff alike
  • Rely on enterprise-grade support from a unified, mission-driven team

“ScribbleVet was built to give veterinarians their time back,” said Rohan Relan, Founder and CEO of ScribbleVet. “We’re excited we found a home with a company that shares that mission and has the platform, clinical depth, and vision to take it even further. With Instinct, we can create something entirely new: a system in which Intelligence is deeply intertwined with how veterinary teams work every day.”

Customers of both Instinct and ScribbleVet will continue using their products as they do today, with no immediate changes. Over time, Instinct will introduce deeper integrations that unify AI scribing, workflow, and clinical intelligence into a single, cohesive experience and ScribbleVet will become the first AI scribe powered by Plumb’s. Instinct will continue to support multiple AI scribe integrations, and ScribbleVet will continue to support multiple PIMS integrations. 

This acquisition positions Instinct at the forefront of a new era in veterinary software, one focused not just on managing practices, but on actively supporting the people who deliver care.

To learn more, read this blog post from Instinct Founder and CEO Caleb Frankel. 

About Instinct Science
Instinct is an animal health technology company on a mission to transform veterinary medicine through thoughtfully designed software and essential clinical decision support tools that support veterinary professionals in delivering lifesaving, compassionate care.

Serving over 360,000 veterinary professionals worldwide, Instinct brings together innovative software with trusted clinical tools like Standards of Care, Plumb’s, and Clinician’s Brief that veterinary teams rely on every day to make critical, informed care decisions.

Founded in 2017 by Dr. Caleb Frankel, an experienced emergency room veterinarian, Instinct empowers veterinary hospitals with the tools to enhance patient outcomes, boost team efficiency, and support continuous learning and professional growth. Through its technology and unique industry expertise, Instinct is redefining what’s possible in veterinary medicine, committed to making life easier and care better for veterinary teams and the animals they serve.

For more information, connect with us on LinkedIn @Instinct or visit instinct.vet.

About ScribbleVet
ScribbleVet is the leading AI-powered scribe for veterinarians, designed to automate the time-consuming task of note-taking. Serving thousands of veterinarians across the country, ScribbleVet helps reduce burnout, improve workflow efficiency, and enable professionals to dedicate more time to patient care. For more information, visit scribblevet.com.

For press inquiries, please contact press@instinct.vet.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/instinct-science-acquires-scribblevet-to-deliver-the-next-generation-of-intelligent-native-veterinary-practice-management-software-302663643.html

SOURCE Instinct Science

Market Opportunity
native coin Logo
native coin Price(NATIVE)
$0.00001924
$0.00001924$0.00001924
-40.00%
USD
native coin (NATIVE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Surge with 20,685 BTC Inflows, Marking Strongest Week

Bitcoin ETFs Surge with 20,685 BTC Inflows, Marking Strongest Week

TLDR Bitcoin ETFs recorded their strongest weekly inflows since July, reaching 20,685 BTC. U.S. Bitcoin ETFs contributed nearly 97% of the total inflows last week. The surge in Bitcoin ETF inflows pushed holdings to a new high of 1.32 million BTC. Fidelity’s FBTC product accounted for 36% of the total inflows, marking an 18-month high. [...] The post Bitcoin ETFs Surge with 20,685 BTC Inflows, Marking Strongest Week appeared first on CoinCentral.
Share
Coincentral2025/09/18 02:30
XAG/USD retreats toward $113.00 on profit-taking pressure

XAG/USD retreats toward $113.00 on profit-taking pressure

The post XAG/USD retreats toward $113.00 on profit-taking pressure appeared on BitcoinEthereumNews.com. Silver price (XAG/USD) halts its seven-day winning streak
Share
BitcoinEthereumNews2026/01/30 10:21
BTC Leverage Builds Near $120K, Big Test Ahead

BTC Leverage Builds Near $120K, Big Test Ahead

The post BTC Leverage Builds Near $120K, Big Test Ahead appeared on BitcoinEthereumNews.com. Key Insights: Heavy leverage builds at $118K–$120K, turning the zone into Bitcoin’s next critical resistance test. Rejection from point of interest with delta divergences suggests cooling momentum after the recent FOMC-driven spike. Support levels at $114K–$115K may attract buyers if BTC fails to break above $120K. BTC Leverage Builds Near $120K, Big Test Ahead Bitcoin was trading around $117,099, with daily volume close to $59.1 billion. The price has seen a marginal 0.01% gain over the past 24 hours and a 2% rise in the past week. Data shared by Killa points to heavy leverage building between $118,000 and $120,000. Heatmap charts back this up, showing dense liquidity bands in that zone. Such clusters of orders often act as magnets for price action, as markets tend to move where liquidity is stacked. Price Action Around the POI Analysis from JoelXBT highlights how Bitcoin tapped into a key point of interest (POI) during the recent FOMC-driven spike. This move coincided with what was called the “zone of max delta pain”, a level where aggressive volume left imbalances in order flow. Source: JoelXBT /X Following the test of this area, BTC faced rejection and began to pull back. Delta indicators revealed extended divergences, with price rising while buyer strength weakened. That mismatch suggests demand failed to keep up with the pace of the rally, leaving room for short-term cooling. Resistance and Support Levels The $118K–$120K range now stands as a major resistance band. A clean move through $120K could force leveraged shorts to cover, potentially driving further upside. On the downside, smaller liquidity clusters are visible near $114K–$115K. If rejection holds at the top, these levels are likely to act as the first supports where buyers may attempt to step in. Market Outlook Bitcoin’s next decisive move will likely form around the…
Share
BitcoinEthereumNews2025/09/18 16:40